BEACON-LUNG Study
Study to identify patients who may benefit from a triplet treatment regimen
ENIGMA Study
Study biological specimens from patients with ALK+ NSCLC
EoYLC Study
Study risk factors for lung cancer in persons under age 50
INHERIT Study
Investigate inherited risk of lung cancer mutations
SPACEWALK Study
Study outcomes of patients with ALK+ TKI Drug Resistance
SPARK Study
Study new mutations after treatment in KRAS lung cancer
